RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Landfar Bio medicine Co Stock

Landfar Bio medicine Co P/E 2024

Landfar Bio medicine Co P/E

-135.48

Ticker

000504.SZ

ISIN

CNE000000263

As of Nov 16, 2024, Landfar Bio medicine Co's P/E ratio was -135.48, a -64.67% change from the -383.42 P/E ratio recorded in the previous year.

The Landfar Bio medicine Co P/E history

Landfar Bio medicine Co Aktienanalyse

What does Landfar Bio medicine Co do?

Landfar Bio medicine Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/E Details

Deciphering Landfar Bio medicine Co's P/E Ratio

The Price to Earnings (P/E) Ratio of Landfar Bio medicine Co is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.

Year-to-Year Comparison

Assessing Landfar Bio medicine Co's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.

Impact on Investments

The P/E ratio of Landfar Bio medicine Co is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.

Interpreting P/E Ratio Fluctuations

Fluctuations in Landfar Bio medicine Co’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.

Frequently Asked Questions about Landfar Bio medicine Co stock

What is the price-to-earnings ratio of Landfar Bio medicine Co?

The price-earnings ratio of Landfar Bio medicine Co is currently -135.48.

How has the price-earnings ratio of Landfar Bio medicine Co changed compared to last year?

The price-to-earnings ratio of Landfar Bio medicine Co has increased by -64.67% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Landfar Bio medicine Co high compared to other companies?

Yes, the price-to-earnings ratio of Landfar Bio medicine Co is high compared to other companies.

How does an increase in the price-earnings ratio of Landfar Bio medicine Co affect the company?

An increase in the price-earnings ratio of Landfar Bio medicine Co would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Landfar Bio medicine Co affect the company?

A decrease in the price-earnings ratio of Landfar Bio medicine Co would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Landfar Bio medicine Co?

Some factors that influence the price-earnings ratio of Landfar Bio medicine Co are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Landfar Bio medicine Co pay?

Over the past 12 months, Landfar Bio medicine Co paid a dividend of 0.03 CNY . This corresponds to a dividend yield of about 0.3 %. For the coming 12 months, Landfar Bio medicine Co is expected to pay a dividend of 0 CNY.

What is the dividend yield of Landfar Bio medicine Co?

The current dividend yield of Landfar Bio medicine Co is 0.3 %.

When does Landfar Bio medicine Co pay dividends?

Landfar Bio medicine Co pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Landfar Bio medicine Co?

Landfar Bio medicine Co paid dividends every year for the past 0 years.

What is the dividend of Landfar Bio medicine Co?

For the upcoming 12 months, dividends amounting to 0 CNY are expected. This corresponds to a dividend yield of 0 %.

In which sector is Landfar Bio medicine Co located?

Landfar Bio medicine Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Landfar Bio medicine Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Landfar Bio medicine Co from 4/23/2004 amounting to 0.03 CNY, you needed to have the stock in your portfolio before the ex-date on 4/23/2004.

When did Landfar Bio medicine Co pay the last dividend?

The last dividend was paid out on 4/23/2004.

What was the dividend of Landfar Bio medicine Co in the year 2023?

In the year 2023, Landfar Bio medicine Co distributed 0 CNY as dividends.

In which currency does Landfar Bio medicine Co pay out the dividend?

The dividends of Landfar Bio medicine Co are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Landfar Bio medicine Co

Our stock analysis for Landfar Bio medicine Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Landfar Bio medicine Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.